| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.1M | $1.4M | $607.0K |
| YoY Revenue Growth % | +271.3% | +124.8% | — |
| Gross Profit | $1.5M | $374.0K | — |
| Gross Margin % | 29.4% | 27.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.1M | -$6.2M | -$8.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$8.5M | -$6.5M | -$9.0M |
| EBITDA (Normalized) | -$7.9M | -$6.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$6.9M | -$3.3M | -$5.7M |
| Capital Expenditures (CapEx) | $315.0K | $27.0K | — |
| Free Cash Flow (FCF) | -$7.2M | -$3.3M | -$5.7M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $8.5M | $52.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $7.6M | -$504.0K | — |